These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 4184472

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Serologic medifications of blood group antigens of erythrocytes in patients with malignant tumors].
    Májský A, Jakoubková J.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(4):353-60. PubMed ID: 4173899
    [No Abstract] [Full Text] [Related]

  • 3. [Serological and karyological changes in patients with blood diseases and malignant neoplasms].
    Májský A, Krecek M, Jakoubková J, Macháckov0a M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(3):311-9. PubMed ID: 4193006
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Serological modifications of blood group antigens from human blood cells in malignant diseases. Causes, serological character and meaning].
    Májský A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(4):281-302. PubMed ID: 4101119
    [No Abstract] [Full Text] [Related]

  • 6. [Studies of modifications of blood group antigens in 11 cases of "refractory anemia"].
    Salmon C, Rochant H, Mannoni P, Cartron JP, Jacquet A, Liberge G, Dreyfus B.
    Nouv Rev Fr Hematol; 1969; 9(1):113-22. PubMed ID: 4237806
    [No Abstract] [Full Text] [Related]

  • 7. Biological and clinical significance of differences between RBC membrane (Rh) and non membrane (ABH, MN, P) antigenic sites.
    Moore BP.
    Rev Fr Transfus Immunohematol; 1976 Dec; 19(4):629-30. PubMed ID: 828769
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Distribution of ABO, rhesus, MN and P blood system groups among patients with blood system diseases].
    Nersisian VM, Torgomian IL, Eliian LN, Uzunian LKh, Shcherbakova LN.
    Probl Gematol Pereliv Krovi; 1972 Oct; 17(10):39-41. PubMed ID: 4202235
    [No Abstract] [Full Text] [Related]

  • 12. A review of serologic problems caused by polyagglutinable red cells.
    Wilson J.
    Am J Med Technol; 1977 Feb; 43(2):147-55. PubMed ID: 402072
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The Ii blood group system: its role in human pathology].
    Dzierzkowa-Borodej W.
    Postepy Hig Med Dosw; 1971 Feb; 25(6):789-810. PubMed ID: 4111461
    [No Abstract] [Full Text] [Related]

  • 18. [A rare variation of group A. The phenotype A2mh (partial suppression of A and total suppression of H in erythrocytes with normal salivary secretions)].
    Lewi S.
    Transfusion (Paris); 1967 Feb; 10(4):335-50. PubMed ID: 4967279
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Current status of the question of the Ii isoserological system (a review of the literature)].
    Mishakova MV.
    Probl Gematol Pereliv Krovi; 1973 May; 18(5):43-7. PubMed ID: 4131273
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.